Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions
- 7 January 2025
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17 (4) , 2058-2085
Abstract
This review delves into the potential of antimicrobial peptides (AMPs) as promising candidates for combating arboviruses, focusing on their mechanisms of antiviral activity, challenges, and future directions. AMPs have shown promise in preventing arbovirus attachment to host cells, inducing interferon production, and targeting multiple viral stages, illustrating their multifaceted impact on arbovirus infections. Structural elucidation of AMP–viral complexes is explored to deepen the understanding of molecular determinants governing viral neutralization, paving the way for structure-guided design. Furthermore, this review highlights the potential of AMP-based combination therapies to create synergistic effects that enhance overall treatment outcomes while minimizing the likelihood of resistance development. Challenges such as susceptibility to proteases, toxicity, and scalable production are discussed alongside strategies to address these limitations. Additionally, the expanding applications of AMPs as vaccine adjuvants and antiviral delivery systems are emphasized, underscoring their versatility beyond direct antiviral functions.Keywords
This publication has 204 references indexed in Scilit:
- VENEZUELAN EQUINE ENCEPHALITISAnnual Review of Entomology, 2004
- Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition proteinNature, 2001
- Antiviral activities of lactoferrinAntiviral Research, 2001
- Amphipathic α helical antimicrobial peptides.European Journal of Biochemistry, 2001
- West Nile Virus in OverwinteringCulexMosquitoes, New York City, 2000Emerging Infectious Diseases, 2001
- Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological surveyThe Lancet, 2001
- Adverse effects of antiretroviral therapyThe Lancet, 2000
- Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cellsVirus Research, 2000
- Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29Medical Microbiology and Immunology, 1997
- Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 moleculeMolecular Immunology, 1994